8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2016 / Double-blind, randomized, crossover trial
In a randomized, double-blind crossover trial, 14 patients with diet-controlled type 2 diabetes received resveratrol (500 mg twice daily) or placebo for two 5-week periods separated by a 5-week washout. Fasting and postprandial blood glucose, plasma total GLP-1, and gastric emptying were similar at each assessment, and changes from weeks 0 to 5 did not differ between resveratrol and placebo. Changes in HbA1c, daily energy intake, and body weight after 5 weeks also showed no significant differences between treatments.
Thazhath SS, Wu T, Bound MJ, et al. Am J Clin Nutr, 2016. PMID 26607942
2016 / Randomized crossover trial
In a randomized crossover trial, healthy young adults underwent 4 nights of normal sleep (8.5 h) versus restricted sleep (4.5 h) to examine 24-h profiles of 2-arachidonoylglycerol (2-AG) and 2-oleoylglycerol (2-OG), along with hunger, appetite, and food intake. Both sleep conditions showed daily 2-AG variation with an overnight nadir and an early afternoon peak, but sleep restriction amplified this rhythm with delayed and extended maximum values. Sleep-restricted participants reported heightened hunger and appetite concurrent with the afternoon 2-AG elevation and were less able to inhibit consumption of palatable snacks.
Hanlon EC, Tasali E, Leproult R, et al. Sleep, 2016. PMID 26612385
2016 / Randomized crossover trial
Fifteen overweight adults consumed four breakfast meals varying in protein (12 g vs. 25 g) and fiber (2 g vs. 8 g) in a randomized crossover design. The amount of protein and fiber consumed at breakfast did not influence postprandial appetite or ad libitum energy intake at lunch. Postprandial right insula responses were lower after consuming normal protein versus high protein breakfasts, while responses in other a priori brain regions were not significantly influenced.
Sayer RD, Amankwaah AF, Tamer GG, et al. Nutrients, 2016. PMID 26742068
2016 / Intervention trial
In 11 habitual consumers of high PAMP foods, adherence to a low PAMP diet for 7 days significantly reduced LDL-cholesterol (-0.69 mM, P = 0.024) and abdominal circumference (-1.6 cm, P = 0.001). Conversely, these markers and leukocyte counts (+14%, P = 0.017) increased significantly after 4 days of consuming predominantly high PAMP foods. In a separate group of 13 healthy men, leukocyte counts and CD11b expression on granulocytes and monocytes were significantly reduced after a fresh onion meal (P < 0.05), but this effect was reversed by a high PAMP equivalent meal.
Herieka M, Faraj TA, Erridge C Nutr Metab Cardiovasc Dis, 2016. PMID 26803597
2016 / Randomized crossover trial
In an acute crossover trial, 10 overweight or obese adults completed three 1-day interventions: isoenergetic intake, 75% energy restriction, and 100% energy restriction. Total restriction increased postprandial glucose response by 142% (P=0.015) and partial restriction increased it by 76% (P=0.051), with delayed glucose peak after total restriction. Both total and partial restriction reduced postprandial triglyceride responses by 75% and 59%, respectively (both P<0.05), and led to incomplete energy compensation over subsequent days.
Antoni R, Johnston KL, Collins AL, et al. Br J Nutr, 2016. PMID 26819200
2016 / Randomized controlled trial
In the Bath Breakfast Project, 23 obese adults were randomly assigned to daily breakfast (≥700 kcal before 1100) or extended fasting (0 kcal until 1200) for 6 weeks under free-living conditions. Breakfast resulted in greater physical activity thermogenesis during the morning (difference: 188 kcal/d; 95% CI: 40, 335), but without a consistent effect over 24 hours. Energy intake was not significantly greater with breakfast (difference: 338 kcal/d; 95% CI: -313, 988). Body mass increased across both groups over time with no treatment effects on body composition or resting metabolic rate, while daily breakfast was associated with a reduced insulinemic response to an oral-glucose-tolerance test relative to an increase with fasting (P = 0.05).
Chowdhury EA, Richardson JD, Holman GD, et al. Am J Clin Nutr, 2016. PMID 26864365
2016 / Randomized crossover trial
A randomized crossover trial tested the satiety effects of 50 grams of flaked biscuits made from white, red, or brown sorghum versus wheat in 40 healthy individuals. Participants reported significantly higher subjective satiety following sorghum breakfasts compared to wheat. In a 20-subject subgroup, sorghum significantly enhanced postprandial incremental area under the curve for GLP-1 (p = 0.018), GIP (p = 0.031), and PYY in males (p = 0.036), though subsequent meal energy intake remained unchanged.
Stefoska-Needham A, Beck EJ, Johnson SK, et al. Mol Nutr Food Res, 2016. PMID 26866508
2016 / Randomized crossover trial
In two crossover trials, 32 children aged 11 to 13 years consumed five carbohydrate sides alongside beef. Children ate 30% to 40% fewer calories when consuming boiled and mashed potatoes compared with pasta, rice, or french fries (P<0.0001). Satiety per kilocalorie was highest with boiled and mashed potatoes (P<0.0001), while fried french fries resulted in the lowest glucose, insulin, and peptide YY concentrations (P<0.0001).
Akilen R, Deljoomanesh N, Hunschede S, et al. Nutr Diabetes, 2016. PMID 26878318
2016 / Randomized, double-blind, placebo-controlled trial
In this trial, 110 subjects with NAFLD were randomly assigned to receive either two garlic tablets daily (containing 400 mg of garlic powder) or placebo tablets. The intervention group demonstrated significant reductions in body weight and body fat mass (P < 0.05). Percentage change in body weight was significantly greater in the intervention group compared to the control group (-2.6 vs. -0.7, P = 0.02). Neither group showed significant changes in total body water or lean body mass (P > 0.05), and no serious side effects were reported.
Soleimani D, Paknahad Z, Askari G, et al. Adv Biomed Res, 2016. PMID 26955623
2016 / Randomized controlled trial
In an open-label trial with 50 adults having non-alcoholic fatty liver disease, participants received either lifestyle changes alone or with 30 grams daily of milled flaxseed for 12 weeks. Both groups improved, but flaxseed produced greater reductions in ALT (-11.12 vs -3.7 U/L), AST (-8.29 vs -4 U/L), GGT (-15.7 vs -2.62 U/L), fibrosis (-1.26 vs -0.77 kPa), and steatosis (-47 vs -15.45 dB/m). Body weight and insulin resistance also decreased more with flaxseed.
Yari Z, Rahimlou M, Eslamparast T, et al. Int J Food Sci Nutr, 2016. PMID 26983396
2016 / Randomized crossover trial
In a randomized crossover study, healthy young adults consumed evening meals of whole grain rye kernel bread (RKB) or white wheat bread (WWB) as either a single meal or across three consecutive evenings. Compared to WWB, the RKB evening meal decreased blood glucose (0-120 min, P = 0.001), serum insulin response (0-120 min, P < 0.05), and fasting free fatty acids (P < 0.05) the next morning. RKB also increased plasma PYY (0-120 min, P < 0.001), GLP-1 (0-90 min, P < 0.05), fasting acetate and butyrate (P < 0.05), breath hydrogen excretion (P < 0.001), and improved subjective appetite ratings (P < 0.05). With the exception of serum CRP, length of priming did not significantly alter outcomes.
Sandberg JC, Björck IM, Nilsson AC PLoS One, 2016. PMID 26990559
2016 / Multicenter randomized controlled trial
Healthy, non-obese participants were randomized 2:1 to 25% caloric restriction or an ad-libitum diet for two years. Overall adverse event rates did not differ significantly between arms, with zero deaths and one serious adverse event reported during caloric restriction. However, participants assigned to caloric restriction developed significantly lower bone mineral density at the lumbar spine, total hip, and femoral neck at 12 and 24 months.
Romashkan SV, Das SK, Villareal DT, et al. Oncotarget, 2016. PMID 26992237
2016 / Clinical trial
Thirty adults with type 2 diabetes followed an eight-week very low-calorie diet before returning to an isocaloric maintenance plan. Body weight dropped from 98.0 ± 2.6 to 83.8 ± 2.4 kg and remained stable at 84.7 ± 2.5 kg at six months. Fasting blood glucose normalized below 7 mmol/L in 12 participants after refeeding and in 13 participants at six months, accompanied by recovered first-phase insulin response.
Steven S, Hollingsworth KG, Al-Mrabeh A, et al. Diabetes Care, 2016. PMID 27002059
2016 / Pilot nutritional intervention
In a pilot nutritional intervention, 25 healthy subjects (mean age 38.3) consumed 12 Nocellara del Belice green table olives daily for 30 days. Results showed a significant variation in malondialdehyde and a significant decrease in interleukin-6 levels. Additionally, a reduction of fat mass with an increase of muscle mass was observed, whereas no statistically significant differences were found in fecal Lactobacilli concentrations despite a trend toward an increase. The authors caution that these preliminary findings must be verified in a larger sample.
Accardi G, Aiello A, Gargano V, et al. Immun Ageing, 2016. PMID 27053940
2016 / Randomized placebo-controlled trial
Researchers evaluated a four-ingredient nutritional mixture (GSK2890457) in rodent models and a six-week randomized trial with healthy participants and adults with type 2 diabetes. In diabetic participants taking liraglutide, the supplement did not lower weight and produced slight decreases in mean glucose and HbA1c compared to placebo. In those taking metformin, weight increased by 1.26%, while mean glucose and HbA1c were decreased slightly versus placebo.
Hodge RJ, Paulik MA, Walker A, et al. PLoS One, 2016. PMID 27093610
2016 / Multicenter randomized controlled trial
In a multisite trial, 218 healthy nonobese adults were randomized to 2 years of 25% calorie restriction or ad libitum intake. The calorie restriction group lost 7.6 kg versus 0.4 kg in controls (P < 0.001). Compared to controls, calorie restriction improved depressive symptoms, tension, general health, and sexual drive at month 24, as well as sleep duration at month 12 (all P < 0.05), with no adverse quality-of-life effects.
Martin CK, Bhapkar M, Pittas AG, et al. JAMA Intern Med, 2016. PMID 27136347
2016 / Randomized controlled trial
A randomized trial assigned 44 patients with metabolic syndrome to lifestyle advice alone or with 30 grams of milled flaxseed daily. Metabolic syndrome rates dropped by 82% in the flaxseed group compared to 50% in controls. The flaxseed group experienced greater reductions in insulin resistance (p < 0.001), body weight, waist circumference, and body mass index, although blood pressure showed no significant alterations.
Yari Z, Rahimlou M, Poustchi H, et al. Phytother Res, 2016. PMID 27151322
2016 / Randomized crossover trial
Twenty healthy nonobese men completed an fMRI food picture evaluation task after consuming control inulin or inulin-propionate ester in a randomized crossover design. Increasing colonic propionate reduced the blood oxygen level-dependent signal in the caudate and nucleus accumbens, with the caudate reduction driven specifically by a decreased response to high-energy food. These effects were accompanied by lower subjective appeal of high-energy food pictures and reduced ad libitum energy intake, without changes in plasma PYY, GLP-1, glucose, or insulin.
Byrne CS, Chambers ES, Alhabeeb H, et al. Am J Clin Nutr, 2016. PMID 27169834
2016 / Randomized controlled trial
In two randomized controlled trials, 55 overweight and obese adults consumed test meals containing varying mycoprotein amounts (44 g, 88 g, or 132 g) or isoenergetic chicken. High mycoprotein decreased subsequent ad libitum energy intake by 10% (280 kJ / 67 kcal, P=0.009) relative to chicken. All mycoprotein meals reduced postprandial insulin concentrations (incremental AUC drops of 8%, 12%, and 21%, P=0.004), without altering glucose, GLP-1, PYY, or energy expenditure.
Bottin JH, Swann JR, Cropp E, et al. Br J Nutr, 2016. PMID 27198187
2016 / Randomized crossover trial
Eleven healthy normal-weight women completed a crossover trial comparing two 14-day isoenergetic diets consumed in regular (6 meals daily) or irregular (3-9 meals daily) patterns. Regular meal timing produced a significantly greater thermic effect of food (P < 0.05) and reduced glucose incremental area under the curve following a test drink and selected meals. Participants also reported lower hunger and greater fullness ratings during the regular intervention.
Alhussain MH, Macdonald IA, Taylor MA Am J Clin Nutr, 2016. PMID 27305952
2016 / Randomized crossover trial
Eight overweight or obese men completed a randomized crossover trial comparing 24 hours of severe energy restriction (25% of energy needs) against energy balance (100%). Ad libitum energy intake did not differ between conditions on day 2 (15,251 kJ vs 14,946 kJ; P=0.623), day 3, or both days combined. Aside from higher post-breakfast NEFA, GIP, and fat oxidation, hormonal appetite markers and day 2 appetite ratings remained unchanged.
Clayton DJ, Creese M, Skidmore N, et al. Int J Obes (Lond), 2016. PMID 27339607
2016 / Randomized controlled trial and animal study
A randomized controlled trial in humans demonstrated that a moderate protein-restricted diet improved markers of metabolic health. In parallel animal experiments, mice provided a diet specifically low in branched-chain amino acids showed improvements in glucose tolerance and body composition comparable to whole protein restriction. These changes operated through distinct metabolic pathways, indicating that dietary amino acid composition directly influences metabolic function.
Fontana L, Cummings NE, Arriola Apelo SI, et al. Cell Rep, 2016. PMID 27346343
2016 / Inpatient sequential-diet feeding study
Seventeen overweight or obese men resided in metabolic wards and consumed a high-carbohydrate diet for four weeks, followed by four weeks on an isocaloric ketogenic diet. Chamber energy expenditure increased by 57 ± 13 kcal/d (P = 0.0004) and doubly labeled water expenditure rose by 151 ± 63 kcal/d (P = 0.03). However, loss of body fat slowed, and participants lost fat-free mass alongside higher protein utilization.
Hall KD, Chen KY, Guo J, et al. Am J Clin Nutr, 2016. PMID 27385608
2016 / 4-arm randomized controlled trial
A 12-month trial randomized 439 overweight/obese postmenopausal women to caloric restriction diet, aerobic exercise, combined diet + exercise, or control. Diet + exercise significantly reduced PAI-1 compared to control (-19.3% vs. +3.48%, P < 0.0001). Both the diet and combined arms showed significant reductions versus controls in PEDF (-9.20% and -9.90%, both P < 0.0001) and VEGF (-8.25%, P = 0.0005; -9.98%, P < 0.0001). Exercise alone produced no differences in any analyte versus control, while greater weight loss linearly correlated with larger biomarker reductions.
Duggan C, Tapsoba Jde D, Wang CY, et al. Cancer Res, 2016. PMID 27417562